This site is intended for patients in Great Britain (England, Scotland and Wales) who have been prescribed PIQRAY®▼ (alpelisib) + fulvestrant.

It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.

Patient Survey

Please take a moment to take our survey to help us find out more about you and what you have found helpful on the portal. We are always looking for ways to improve and ensure you are finding the information you require. Thank you for your time.

How the data you provide will be used

 All data collected as part of this survey will be kept anonymous in accordance with the UK General Data Protection Regulation (UK GDPR) and Data Protection Act 2018. Findings will be summarised in a report to improve the patient website experience for patinents treated with Piqray.

For more information on how we will handle your personal data and your rights, please refer to the privacy policy.

About you 1 of 4
How many months have you been on treatment?
How easy did you find access to this website?
How easy have you found this site to navigate?

▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See for how to report side effects.

UK | December 2021 | 158903